SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Multi-Center 3D CNN for Parkinson's disease diagnosis and prognosis using clinical and T1-weighted MRI data.

Neuroimage Clin · 2025-08-05

DOI: 10.1016/j.nicl.2025.103859PMID: 40773786

Open accessResearch Support, Non-U.S. Gov't; research-article; Multicenter Study; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

ObjectiveParkinson's disease (PD) presents challenges in early diagnosis and progression prediction. Recent advancements in machine learning, particularly convolutional-neural-networks (CNNs), show promise in enhancing diagnostic accuracy and prognostic capabilities using neuroimaging data. The aims of this study were: (i) develop a 3D-CNN based on MRI to distinguish controls and PD patients and (ii) employ CNN to predict the progression of PD.MethodsThree cohorts were selected: 86 mild, 62 moderate-to-severe PD patients, and 60 controls; 14 mild-PD patients and 14 controls from Parkinson's Progression Markers Initiative database, and 38 de novo mild-PD patients and 38 controls. All participants underwent MRI scans and clinical evaluation at baseline and over 2-years. PD subjects were classified in two clusters of different progression using k-means clustering based on baseline and follow-up UDPRS-III scores. A 3D-CNN was built and tested on PD patients and controls, with binary classifications: controls vs moderate-to-severe PD, controls vs mild-PD, and two clusters of PD progression. The effect of transfer learning was also tested.ResultsCNN effectively differentiated moderate-to-severe PD from controls (74% accuracy) using MRI data alone. Transfer learning significantly improved performance in distinguishing mild-PD from controls (64% accuracy). For predicting disease progression, the model achieved over 70% accuracy by combining MRI and clinical data. Brain regions most influential in the CNN's decisions were visualized.ConclusionsCNN, integrating multimodal data and transfer learning, provides encouraging results toward early-stage classification and progression monitoring in PD. Its explainability through activation maps offers potential for clinical application in early diagnosis and personalized monitoring.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.